Skip to main content
Top
Published in: Journal of Translational Medicine 1/2010

Open Access 01-12-2010 | Research

Boosting high-intensity focused ultrasound-induced anti-tumor immunity using a sparse-scan strategy that can more effectively promote dendritic cell maturation

Authors: Fang Liu, Zhenlin Hu, Lei Qiu, Chun Hui, Chao Li, Pei Zhong, Junping Zhang

Published in: Journal of Translational Medicine | Issue 1/2010

Login to get access

Abstract

Background

The conventional treatment protocol in high-intensity focused ultrasound (HIFU) therapy utilizes a dense-scan strategy to produce closely packed thermal lesions aiming at eradicating as much tumor mass as possible. However, this strategy is not most effective in terms of inducing a systemic anti-tumor immunity so that it cannot provide efficient micro-metastatic control and long-term tumor resistance. We have previously provided evidence that HIFU may enhance systemic anti-tumor immunity by in situ activation of dendritic cells (DCs) inside HIFU-treated tumor tissue. The present study was conducted to test the feasibility of a sparse-scan strategy to boost HIFU-induced anti-tumor immune response by more effectively promoting DC maturation.

Methods

An experimental HIFU system was set up to perform tumor ablation experiments in subcutaneous implanted MC-38 and B16 tumor with dense- or sparse-scan strategy to produce closely-packed or separated thermal lesions. DCs infiltration into HIFU-treated tumor tissues was detected by immunohistochemistry and flow cytometry. DCs maturation was evaluated by IL-12/IL-10 production and CD80/CD86 expression after co-culture with tumor cells treated with different HIFU. HIFU-induced anti-tumor immune response was evaluated by detecting growth-retarding effects on distant re-challenged tumor and tumor-specific IFN-γ-secreting cells in HIFU-treated mice.

Results

HIFU exposure raised temperature up to 80 degrees centigrade at beam focus within 4 s in experimental tumors and led to formation of a well-defined thermal lesion. The infiltrated DCs were recruited to the periphery of lesion, where the peak temperature was only 55 degrees centigrade during HIFU exposure. Tumor cells heated to 55 degrees centigrade in 4-s HIFU exposure were more effective to stimulate co-cultured DCs to mature. Sparse-scan HIFU, which can reserve 55 degrees-heated tumor cells surrounding the separated lesions, elicited an enhanced anti-tumor immune response than dense-scan HIFU, while their suppressive effects on the treated primary tumor were maintained at the same level. Flow cytometry analysis showed that sparse-scan HIFU was more effective than dense-scan HIFU in enhancing DC infiltration into tumor tissues and promoting their maturation in situ.

Conclusion

Optimizing scan strategy is a feasible way to boost HIFU-induced anti-tumor immunity by more effectively promoting DC maturation.
Appendix
Available only for authorised users
Literature
1.
go back to reference Hynynen K, Pomeroy O, Smith DN, Huber PE, McDannold NJ, Kettenbach J, Baum J, Singer S, Jolesz FA: MR imaging-guided focused ultrasound surgery of fibroadenomas in the breast: a feasibility study. Radiology. 2001, 219: 176-185.PubMedCrossRef Hynynen K, Pomeroy O, Smith DN, Huber PE, McDannold NJ, Kettenbach J, Baum J, Singer S, Jolesz FA: MR imaging-guided focused ultrasound surgery of fibroadenomas in the breast: a feasibility study. Radiology. 2001, 219: 176-185.PubMedCrossRef
2.
go back to reference Chaussy C, Thuroff S: The status of high-intensity focused ultrasound in the treatment of localized prostate cancer and the impact of a combined resection. Curr Urol Rep. 2003, 4: 248-252. 10.1007/s11934-003-0077-0.PubMedCrossRef Chaussy C, Thuroff S: The status of high-intensity focused ultrasound in the treatment of localized prostate cancer and the impact of a combined resection. Curr Urol Rep. 2003, 4: 248-252. 10.1007/s11934-003-0077-0.PubMedCrossRef
3.
go back to reference Kennedy JE, Wu F, ter Haar GR, Gleeson FV, Phillips RR, Middleton MR, Cranston D: High-intensity focused ultrasound for the treatment of liver tumours. Ultrasonics. 2004, 42: 931-935. 10.1016/j.ultras.2004.01.089.PubMedCrossRef Kennedy JE, Wu F, ter Haar GR, Gleeson FV, Phillips RR, Middleton MR, Cranston D: High-intensity focused ultrasound for the treatment of liver tumours. Ultrasonics. 2004, 42: 931-935. 10.1016/j.ultras.2004.01.089.PubMedCrossRef
4.
go back to reference Chen W, Wang Z, Wu F, Zhu H, Zou J, Bai J, Li K, Xie F: [High intensity focused ultrasound in the treatment of primary malignant bone tumor]. Zhonghua Zhong Liu Za Zhi. 2002, 24: 612-615.PubMed Chen W, Wang Z, Wu F, Zhu H, Zou J, Bai J, Li K, Xie F: [High intensity focused ultrasound in the treatment of primary malignant bone tumor]. Zhonghua Zhong Liu Za Zhi. 2002, 24: 612-615.PubMed
5.
go back to reference Zhang L, Chen WZ, Liu YJ, Hu X, Zhou K, Chen L, Peng S, Zhu H, Zou HL, Bai J, Wang ZB: Feasibility of magnetic resonance imaging-guided high intensity focused ultrasound therapy for ablating uterine fibroids in patients with bowel lies anterior to uterus. Eur J Radiol. 2008 Zhang L, Chen WZ, Liu YJ, Hu X, Zhou K, Chen L, Peng S, Zhu H, Zou HL, Bai J, Wang ZB: Feasibility of magnetic resonance imaging-guided high intensity focused ultrasound therapy for ablating uterine fibroids in patients with bowel lies anterior to uterus. Eur J Radiol. 2008
6.
go back to reference Xiong LL, Hwang JH, Huang XB, Yao SS, He CJ, Ge XH, Ge HY, Wang XF: Early clinical experience using high intensity focused ultrasound for palliation of inoperable pancreatic cancer. Jop. 2009, 10: 123-129.PubMed Xiong LL, Hwang JH, Huang XB, Yao SS, He CJ, Ge XH, Ge HY, Wang XF: Early clinical experience using high intensity focused ultrasound for palliation of inoperable pancreatic cancer. Jop. 2009, 10: 123-129.PubMed
7.
go back to reference Thuroff S, Chaussy C, Vallancien G, Wieland W, Kiel HJ, Le Duc A, Desgrandchamps F, De La Rosette JJ, Gelet A: High-intensity focused ultrasound and localized prostate cancer: efficacy results from the European multicentric study. J Endourol. 2003, 17: 673-677. 10.1089/089277903322518699.PubMedCrossRef Thuroff S, Chaussy C, Vallancien G, Wieland W, Kiel HJ, Le Duc A, Desgrandchamps F, De La Rosette JJ, Gelet A: High-intensity focused ultrasound and localized prostate cancer: efficacy results from the European multicentric study. J Endourol. 2003, 17: 673-677. 10.1089/089277903322518699.PubMedCrossRef
8.
go back to reference Wu F, Wang ZB, Chen WZ, Wang W, Gui Y, Zhang M, Zheng G, Zhou Y, Xu G, Li M: Extracorporeal high intensity focused ultrasound ablation in the treatment of 1038 patients with solid carcinomas in China: an overview. Ultrason Sonochem. 2004, 11: 149-154. 10.1016/j.ultsonch.2004.01.011.PubMedCrossRef Wu F, Wang ZB, Chen WZ, Wang W, Gui Y, Zhang M, Zheng G, Zhou Y, Xu G, Li M: Extracorporeal high intensity focused ultrasound ablation in the treatment of 1038 patients with solid carcinomas in China: an overview. Ultrason Sonochem. 2004, 11: 149-154. 10.1016/j.ultsonch.2004.01.011.PubMedCrossRef
9.
go back to reference Visioli AG, Rivens IH, ter Haar GR, Horwich A, Huddart RA, Moskovic E, Padhani A, Glees J: Preliminary results of a phase I dose escalation clinical trial using focused ultrasound in the treatment of localised tumours. Eur J Ultrasound. 1999, 9: 11-18. 10.1016/S0929-8266(99)00009-9.PubMedCrossRef Visioli AG, Rivens IH, ter Haar GR, Horwich A, Huddart RA, Moskovic E, Padhani A, Glees J: Preliminary results of a phase I dose escalation clinical trial using focused ultrasound in the treatment of localised tumours. Eur J Ultrasound. 1999, 9: 11-18. 10.1016/S0929-8266(99)00009-9.PubMedCrossRef
10.
go back to reference Wu F, Wang ZB, Chen WZ, Zou JZ, Bai J, Zhu H, Li KQ, Xie FL, Jin CB, Su HB, Gao GW: Extracorporeal focused ultrasound surgery for treatment of human solid carcinomas: early Chinese clinical experience. Ultrasound Med Biol. 2004, 30: 245-260. 10.1016/j.ultrasmedbio.2003.10.010.PubMedCrossRef Wu F, Wang ZB, Chen WZ, Zou JZ, Bai J, Zhu H, Li KQ, Xie FL, Jin CB, Su HB, Gao GW: Extracorporeal focused ultrasound surgery for treatment of human solid carcinomas: early Chinese clinical experience. Ultrasound Med Biol. 2004, 30: 245-260. 10.1016/j.ultrasmedbio.2003.10.010.PubMedCrossRef
11.
go back to reference Van Leenders GJ, Beerlage HP, Ruijter ET, de la Rosette JJ, Kaa van de CA: Histopathological changes associated with high intensity focused ultrasound (HIFU) treatment for localised adenocarcinoma of the prostate. J Clin Pathol. 2000, 53: 391-394. 10.1136/jcp.53.5.391.PubMedPubMedCentralCrossRef Van Leenders GJ, Beerlage HP, Ruijter ET, de la Rosette JJ, Kaa van de CA: Histopathological changes associated with high intensity focused ultrasound (HIFU) treatment for localised adenocarcinoma of the prostate. J Clin Pathol. 2000, 53: 391-394. 10.1136/jcp.53.5.391.PubMedPubMedCentralCrossRef
12.
go back to reference Wu F, Wang ZB, Lu P, Xu ZL, Chen WZ, Zhu H, Jin CB: Activated anti-tumor immunity in cancer patients after high intensity focused ultrasound ablation. Ultrasound Med Biol. 2004, 30: 1217-1222. 10.1016/j.ultrasmedbio.2004.08.003.PubMedCrossRef Wu F, Wang ZB, Lu P, Xu ZL, Chen WZ, Zhu H, Jin CB: Activated anti-tumor immunity in cancer patients after high intensity focused ultrasound ablation. Ultrasound Med Biol. 2004, 30: 1217-1222. 10.1016/j.ultrasmedbio.2004.08.003.PubMedCrossRef
13.
go back to reference Zhou Q, Zhu XQ, Zhang J, Xu ZL, Lu P, Wu F: Changes in circulating immunosuppressive cytokine levels of cancer patients after high intensity focused ultrasound treatment. Ultrasound Med Biol. 2008, 34: 81-87. 10.1016/j.ultrasmedbio.2007.07.013.PubMedCrossRef Zhou Q, Zhu XQ, Zhang J, Xu ZL, Lu P, Wu F: Changes in circulating immunosuppressive cytokine levels of cancer patients after high intensity focused ultrasound treatment. Ultrasound Med Biol. 2008, 34: 81-87. 10.1016/j.ultrasmedbio.2007.07.013.PubMedCrossRef
14.
go back to reference Banchereau J, Steinman RM: Dendritic cells and the control of immunity. Nature. 1998, 392: 245-252. 10.1038/32588.PubMedCrossRef Banchereau J, Steinman RM: Dendritic cells and the control of immunity. Nature. 1998, 392: 245-252. 10.1038/32588.PubMedCrossRef
15.
go back to reference Takahashi A, Kono K, Ichihara F, Sugai H, Fujii H, Matsumoto Y: Vascular endothelial growth factor inhibits maturation of dendritic cells induced by lipopolysaccharide, but not by proinflammatory cytokines. Cancer Immunol Immunother. 2004, 53: 543-550. 10.1007/s00262-003-0466-8.PubMedCrossRef Takahashi A, Kono K, Ichihara F, Sugai H, Fujii H, Matsumoto Y: Vascular endothelial growth factor inhibits maturation of dendritic cells induced by lipopolysaccharide, but not by proinflammatory cytokines. Cancer Immunol Immunother. 2004, 53: 543-550. 10.1007/s00262-003-0466-8.PubMedCrossRef
16.
go back to reference Almand B, Clark JI, Nikitina E, van Beynen J, English NR, Knight SC, Carbone DP, Gabrilovich DI: Increased production of immature myeloid cells in cancer patients: a mechanism of immunosuppression in cancer. J Immunol. 2001, 166: 678-689.PubMedCrossRef Almand B, Clark JI, Nikitina E, van Beynen J, English NR, Knight SC, Carbone DP, Gabrilovich DI: Increased production of immature myeloid cells in cancer patients: a mechanism of immunosuppression in cancer. J Immunol. 2001, 166: 678-689.PubMedCrossRef
17.
go back to reference Satthaporn S, Robins A, Vassanasiri W, El-Sheemy M, Jibril JA, Clark D, Valerio D, Eremin O: Dendritic cells are dysfunctional in patients with operable breast cancer. Cancer Immunol Immunother. 2004, 53: 510-518. 10.1007/s00262-003-0485-5.PubMedCrossRef Satthaporn S, Robins A, Vassanasiri W, El-Sheemy M, Jibril JA, Clark D, Valerio D, Eremin O: Dendritic cells are dysfunctional in patients with operable breast cancer. Cancer Immunol Immunother. 2004, 53: 510-518. 10.1007/s00262-003-0485-5.PubMedCrossRef
18.
go back to reference Tesniere A, Panaretakis T, Kepp O, Apetoh L, Ghiringhelli F, Zitvogel L, Kroemer G: Molecular characteristics of immunogenic cancer cell death. Cell Death Differ. 2008, 15: 3-12. 10.1038/sj.cdd.4402269.PubMedCrossRef Tesniere A, Panaretakis T, Kepp O, Apetoh L, Ghiringhelli F, Zitvogel L, Kroemer G: Molecular characteristics of immunogenic cancer cell death. Cell Death Differ. 2008, 15: 3-12. 10.1038/sj.cdd.4402269.PubMedCrossRef
19.
go back to reference Hu Z, Yang XY, Liu Y, Morse MA, Lyerly HK, Clay TM, Zhong P: Release of endogenous danger signals from HIFU-treated tumor cells and their stimulatory effects on APCs. Biochem Biophys Res Commun. 2005, 335: 124-131. 10.1016/j.bbrc.2005.07.071.PubMedPubMedCentralCrossRef Hu Z, Yang XY, Liu Y, Morse MA, Lyerly HK, Clay TM, Zhong P: Release of endogenous danger signals from HIFU-treated tumor cells and their stimulatory effects on APCs. Biochem Biophys Res Commun. 2005, 335: 124-131. 10.1016/j.bbrc.2005.07.071.PubMedPubMedCentralCrossRef
20.
go back to reference Hu Z, Yang XY, Liu Y, Sankin GN, Pua EC, Morse MA, Lyerly HK, Clay TM, Zhong P: Investigation of HIFU-induced anti-tumor immunity in a murine tumor model. J Transl Med. 2007, 5: 34-10.1186/1479-5876-5-34.PubMedPubMedCentralCrossRef Hu Z, Yang XY, Liu Y, Sankin GN, Pua EC, Morse MA, Lyerly HK, Clay TM, Zhong P: Investigation of HIFU-induced anti-tumor immunity in a murine tumor model. J Transl Med. 2007, 5: 34-10.1186/1479-5876-5-34.PubMedPubMedCentralCrossRef
21.
go back to reference Preynat-Seauve O, Schuler P, Contassot E, Beermann F, Huard B, French LE: Tumor-infiltrating dendritic cells are potent antigen-presenting cells able to activate T cells and mediate tumor rejection. J Immunol. 2006, 176: 61-67.PubMedCrossRef Preynat-Seauve O, Schuler P, Contassot E, Beermann F, Huard B, French LE: Tumor-infiltrating dendritic cells are potent antigen-presenting cells able to activate T cells and mediate tumor rejection. J Immunol. 2006, 176: 61-67.PubMedCrossRef
22.
go back to reference Hill CR, Rivens I, Vaughan MG, ter Haar GR: Lesion development in focused ultrasound surgery: a general model. Ultrasound Med Biol. 1994, 20: 259-269. 10.1016/0301-5629(94)90066-3.PubMedCrossRef Hill CR, Rivens I, Vaughan MG, ter Haar GR: Lesion development in focused ultrasound surgery: a general model. Ultrasound Med Biol. 1994, 20: 259-269. 10.1016/0301-5629(94)90066-3.PubMedCrossRef
23.
go back to reference Kramer G, Steiner GE, Grobl M, Hrachowitz K, Reithmayr F, Paucz L, Newman M, Madersbacher S, Gruber D, Susani M, Marberger M: Response to sublethal heat treatment of prostatic tumor cells and of prostatic tumor infiltrating T-cells. Prostate. 2004, 58: 109-120. 10.1002/pros.10314.PubMedCrossRef Kramer G, Steiner GE, Grobl M, Hrachowitz K, Reithmayr F, Paucz L, Newman M, Madersbacher S, Gruber D, Susani M, Marberger M: Response to sublethal heat treatment of prostatic tumor cells and of prostatic tumor infiltrating T-cells. Prostate. 2004, 58: 109-120. 10.1002/pros.10314.PubMedCrossRef
24.
go back to reference Tsan MF, Gao B: Heat shock proteins and immune system. J Leukoc Biol. 2009, 85: 905-910. 10.1189/jlb.0109005.PubMedCrossRef Tsan MF, Gao B: Heat shock proteins and immune system. J Leukoc Biol. 2009, 85: 905-910. 10.1189/jlb.0109005.PubMedCrossRef
25.
go back to reference Trinchieri G: Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat Rev Immunol. 2003, 3: 133-146. 10.1038/nri1001.PubMedCrossRef Trinchieri G: Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat Rev Immunol. 2003, 3: 133-146. 10.1038/nri1001.PubMedCrossRef
26.
go back to reference Vicari AP, Trinchieri G: Interleukin-10 in viral diseases and cancer: exiting the labyrinth. Immunol Rev. 2004, 202: 223-236. 10.1111/j.0105-2896.2004.00216.x.PubMedCrossRef Vicari AP, Trinchieri G: Interleukin-10 in viral diseases and cancer: exiting the labyrinth. Immunol Rev. 2004, 202: 223-236. 10.1111/j.0105-2896.2004.00216.x.PubMedCrossRef
27.
go back to reference Gabrilovich DI, Ciernik IF, Carbone DP: Dendritic cells in antitumor immune responses. I. Defective antigen presentation in tumor-bearing hosts. Cell Immunol. 1996, 170: 101-110. 10.1006/cimm.1996.0139.PubMedCrossRef Gabrilovich DI, Ciernik IF, Carbone DP: Dendritic cells in antitumor immune responses. I. Defective antigen presentation in tumor-bearing hosts. Cell Immunol. 1996, 170: 101-110. 10.1006/cimm.1996.0139.PubMedCrossRef
Metadata
Title
Boosting high-intensity focused ultrasound-induced anti-tumor immunity using a sparse-scan strategy that can more effectively promote dendritic cell maturation
Authors
Fang Liu
Zhenlin Hu
Lei Qiu
Chun Hui
Chao Li
Pei Zhong
Junping Zhang
Publication date
01-12-2010
Publisher
BioMed Central
Published in
Journal of Translational Medicine / Issue 1/2010
Electronic ISSN: 1479-5876
DOI
https://doi.org/10.1186/1479-5876-8-7

Other articles of this Issue 1/2010

Journal of Translational Medicine 1/2010 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.